Regeneron (NASDAQ: REGN) reported Q3 EPS of $12.46, $0.74 better than the analyst estimate of $11.72. Revenue for the quarter came in at $3.72 billion versus the consensus estimate of $3.66 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.